Coronavirus Disease 2019 (COVID-19): COVID-19 Vaccine Information

For more information on the planning and distribution process identified by the Wisconsin Department of Health Services (DHS), view the COVID-19 vaccination plan DHS submitted to the Center for Disease Control and Prevention (CDC). The latest information on phase plans and vaccines allocated and administered in Wisconsin can be found on the DHS website.

The New England Journal of Medicine published the full text of the paper describing the study of the Pfizer-BioNTech vaccine, noting in the abstract, “The safety profile of BNT162b2 was characterized by short-term, mild-to-moderate pain at the injection site, fatigue, and headache. The incidence of serious adverse events was low and was similar in the vaccine and placebo groups.” It also highlighted that there was a 95% protection against COVID-19 in people age 16 or older.

Pfizer-BioNTech COVID-19 Vaccine - The Federal Drug Administration answers "Frequently Asked Questions" on the Pfizer-BioNTech vaccine

Moderna COVID-19 Vaccine - The Federal Drug Administration answers "Frequently Asked Questions" on the Moderna vaccine

Find information for COVID-19 vaccination on each specific vaccine as it becomes available. 

• COVID-19 Vaccination Information - The Center for Disease Control and Prevention (CDC) 
• COVID-19 vaccines: Get the facts - Mayo Clinic Frequently asked questions on the available COVID-19 vaccines
• Understanding mRNA COVID-19 Vaccines - The CDC explains what mRNA is and how it works in the vaccine

Johnson & Johnson (Janssen) Phase 3 Clinical Trials are underway. 

• Fourth large-scale COVID-19 vaccine trial begins in the United States
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants (ENSEMBLE)

AstraZeneca COVID-19 Vaccine

• "Oxford–AstraZeneca COVID-19 vaccine efficacy" (2020) The Lancet
• UK becomes world's first to roll out Oxford/AstraZeneca vaccine as cases surge

Novavax COVID-19 Vaccine

• Phase 3 trial of Novavax investigational COVID-19 vaccine opens